HAS Issues Cardiovascular Guidelines Centering Patients, Lifestyle Before Drugs

France’s national health authority, the HAS, issued new cardiovascular care guidelines on Thursday that put the patient — not the prescription pad — at the center of prevention, telling doctors to exhaust lifestyle changes negotiated with each person before reaching for medication.

The move comes as more than one million people are hospitalized in France each year after a cardiovascular event.

The recommendations from the Haute Autorité de Santé (HAS), France’s independent health authority, frame drug treatment as a step that follows — rather than replaces — a conversation about the patient’s daily life. “We really put the emphasis on a patient-centered approach (…) and on really looking at all the risk factors, in a global approach,” Dr Clarisse Dibao-Dina, president of the working group behind the guidance, told reporters at a press conference.

That changes what a French patient can expect at a routine visit. Rather than treating high blood pressure, cholesterol, smoking or excess weight as separate problems to be drugged one by one, generalists, cardiologists, diabetologists, pharmacists and nutritionists are now asked to assess overall risk and agree on changes the patient can actually sustain.

“The drug strategy arrives in this context,” Dibao-Dina added — built on “medications with a genuinely favorable benefit-risk balance” and deployed only after “all the non-drug interventions, negotiated with the patient.”

The stakes are quantified: France’s Health Ministry, following a law passed in July and first États généraux on the subject, unveiled a 2026–2030 roadmap in mid-October targeting a 15% reduction in overall mortality from cardio-neurovascular disease and a 10% cut in premature deaths before age 75 by 2030, according to France 24.

Doctors should assess full cardiovascular profile first

  • Doctors should first identify your cardiovascular risk using your full profile — family history, blood pressure, blood sugar, cholesterol, smoking, alcohol, diet and physical activity — not each factor in isolation.
  • Lifestyle changes you agree to, and can realistically keep, come before medication; drugs are added only if needed, on top of those changes.
  • Statins are strongly recommended for people with several risk factors and after a first cardiovascular event; daily low-dose aspirin is reserved only for people who have already had an event.

Why the HAS wants the whole picture, not one number

The authority’s logic is cumulative: cardiovascular risk depends on fixed factors — age, sex, heredity — but also on modifiable ones including smoking, alcohol use, physical inactivity, sedentary behavior, excess weight, diabetes, poor diet, high blood pressure and high cholesterol. As the HAS’s own framing: the more these factors accumulate, the more health risk rises.

The recommended assessment combines a clinical exam — blood pressure, body mass index — with blood tests such as fasting glucose and a lipid and liver panel. Further investigations, including an ECG, an ultrasound Doppler scan or a coronary calcium score, will be “discussed case by case.”

The goals, the HAS says, are changes that are “progressive, realistic and adapted to the situation” of each patient, taking account of their “priorities,” “daily constraints” and “preferences.”

The HAS’s ambition is explicit: to reduce the number of cardiovascular events in the population and the associated mortality, by spotting risks as early as possible.

What the blood pressure numbers actually mean

The practical detail behind “patient-centered” care is set out in France’s national health insurance guidance. Per ameli.fr, the French health insurer’s practitioner portal, hypertension — high blood pressure — is diagnosed at readings of 140/90 mmHg or higher (but below 180/110) measured at the doctor’s office across three consultations, with at least two measurements per visit, according to Ameli. Severe hypertension is 180/110 or above straight away.

Ameli.fr notes a gap the HAS guidance targets: in France, 20% of known hypertensive patients are untreated, and people with high blood pressure have poor knowledge of their condition — a recognized barrier to taking medication as prescribed. Lowering blood pressure demonstrably reduces the risk of stroke, myocardial infarction (a heart attack) and cardiovascular death, and delays progression to end-stage kidney failure, per that guidance.

Measurement Threshold Context
Hypertension diagnosis ≥ 140/90 mmHg, below 180/110 In-clinic, 3 consultations, ≥ 2 measures per visit
Severe hypertension ≥ 180/110 mmHg On initial measurement
Out-of-clinic confirmation Systolic ≥ 135 or diastolic ≥ 85 mmHg Home self-measurement or ambulatory monitoring
Orthostatic hypotension Drop of ≥ 20 mmHg systolic and/or ≥ 10 mmHg diastolic Within 3 minutes of standing

Home self-measurement, recommended for confirming the diagnosis outside the clinic, uses those lower thresholds. The hustle of a consulting room can raise readings; ameli.fr advises a validated arm cuff, repeated measures at both arms at the first visit, and a check for a blood-pressure drop on standing — mainly in diabetic, Parkinson’s or older patients, where it signals cardiovascular risk and fall danger.

Statins cut recurrence risk; aspirin limited to secondary prevention

The drug strategy has firm boundaries. Statins — cholesterol-lowering drugs — should be offered to people with several risk factors, and are strongly recommended after a cardiovascular event because they cut the risk of recurrence and death, the HAS said. Low-dose aspirin must be reserved for secondary prevention: preventing a second event in people who have already had one, not guarding healthy people.

“There is a very strong correlation between flare-ups of heart failure and seasonal infections, whether viral or bacterial.”

— Professor Bogdan Catargi, vice-president of the HAS working group

That correlation is why influenza vaccination is strongly recommended from age 65 in the new guidance.

Where France sits among global prevention systems

How France’s generalist workforce — already carrying most prevention, per ameli.fr — absorbs the workload of negotiated lifestyle plans is not addressed in the material published.

Contraindications & When to Consult a Doctor

The guidance itself flags the smooth edges: low-dose aspirin should not be used by people without a prior cardiovascular event, since it is reserved for secondary prevention under the HAS recommendations. Statins are positioned for people with several risk factors or after an event — a doctor should assess eligibility case by case, weighing the “genuinely favorable benefit-risk balance” the HAS describes.

A blood pressure of 180/110 mmHg or higher measured once warrants immediate medical contact, per the ameli.fr thresholds. Anyone monitoring at home who records systolic readings at or above 135 mmHg should confirm the diagnosis with their physician, ameli.fr advises. Screening for the blood-pressure drop on standing is recommended mainly for diabetic, Parkinson’s or older patients.

The guidance lands in a country of more than 69.1 million people, spread across 18 integral regions — five of them overseas, from French Guiana in South America to islands in the Indian Ocean — with Paris, home to a metropolitan population of over 13 million, serving as the capital and main economic centre. The Fifth Republic that issued the July law and the 2026–2030 roadmap dates to 1958, when it was formed by Charles de Gaulle.

France’s reach in health policy rests on broader foundations: the country ranks among the largest economies in the world, hosts 54 UNESCO World Heritage Sites, and retains its centuries-long status as a global centre of science and philosophy — the record against which any national prevention effort is measured.

The open question: will negotiated care reach the million?

The working group’s patient-by-patient bargain — realistic changes, agreed priorities, drugs only after they fail — presumes time and continuity with a generalist. Whether that capacity exists for the more than one million people hospitalized each year after a cardiovascular accident is the question the 2026–2030 roadmap, with its 15% and 10% mortality-reduction targets, does not yet answer. The HAS work published Thursday is the first structural move; the ministry’s targets run to 2030.

References

  • Hautée Autorité de Santé (HAS) recommendations on cardiovascular disease management, published Thursday.
  • HAS press conference remarks by Dr Clarisse Dibao-Dina and Pr Bogdan Catargi.
  • ameli.fr (Assurance Maladie), practitioner guidance: “Dépistage et suivi de l’hypertension artérielle : placer le patient au centre de sa prise en charge.”
  • French Ministry of Health, cardio-neurovascular roadmap 2026–2030, unveiled mid-October.
Photo of author

Health Desk

Health Desk at Archyde.

Samsung Pushes Second November Update to Galaxy Z Fold 8, Z Fold 8 Ultra, Z Flip 8

Is Pinterest Cheap? Simply Wall St’s Analyst Consensus Says Yes